{"raw_mentions": "Unfortunately, there are no sentences in the provided text that meet the specified criteria, as they do not contain a specific molecule name, a bioactivity metric (IC50, Ki, Kd, EC50), a numeric value for that metric, and a unit for that value. The text primarily lists various inhibitors and compounds without providing specific bioactivity data."}
{"raw_mentions": "There are no sentences that meet the specified criteria in the provided text snippet. The text appears to describe methods and compounds in general terms, but does not provide specific numeric values for bioactivity metrics (IC50, Ki, Kd, EC50) along with units for any molecule or compound."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe standard assay concentrations for enzyme, ATP, and substrate are 0.5-1.1 nM, l\u03bcM, and 7.5 \u03bcM, respectively.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 9 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 5 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 3 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 1.5 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 1 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 0.6 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 0.3 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 0.2 \u03bcM or less.\nIn another embodiment, the PI3K inhibitor is selected from the compounds in Table 1 having a PI3K-binding affinity of about 0.1 \u03bcM or less."}
{"final_json": [{"molecule_name": null, "protein_target_name": "enzyme", "binding_metric": null, "value": "0.5-1.1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ATP", "binding_metric": null, "value": "1", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "substrate", "binding_metric": null, "value": "7.5", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<9", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<5", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<3", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<1.5", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<1", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<0.6", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<0.3", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<0.2", "unit": "\u03bcM"}, {"molecule_name": "compounds in Table 1", "protein_target_name": "PI3K", "binding_metric": "binding affinity", "value": "<0.1", "unit": "\u03bcM"}]}
